FDA Advisers Say Yes to Experimental Personalized Cancer Therapy - NBCNews.com

NBCNews.com

FDA Advisers Say Yes to Experimental Personalized Cancer Therapy NBCNews.com This particular treatment, which has the tongue-twisting name tisagenlecleucel, is made by Novartis and it's one of several being developed by drug companies that want to try to standardize the approach as much as possible so it can be patented and ... and more »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2ukwNaT
via IFTTT